

Latest news about signalling science and CIBSS scientists
'Blood washing' with light makes cancer immunotherapies much more tolerable.
A successful clinical study led by CIBSS member Prof. Dr. Robert Zeiser has shown that blood cells exposed to UV light reduce inflammatory reactions controlled by a lipid metabolism molecule.
MoreBreaking Barriers: New Seed Money Funding for Plant Cell Wall Permeability Study
Eucor - The European Campus is funding four cross-border research projects, including one by CIBSS member Prof. Dr. Laura Ragni on the regulation of hydrophobic biopolymers in plant cells
MoreInnovative cancer treatment receives major EU funding
Start-up EMUNO Therapeutics receives €2.5 million EIC Transition Grant
MoreResearchers have a better understanding of how our cells dispose of waste while developing ways to control it
A research team from Freiburg and Frankfurt has discovered how cells recognise and internally break down waste. The results are relevant for the development of therapies for diseases such as Alzheimer's.
MoreHow rare gene variants influence metabolism
Study identifies new links between genes and metabolites / Publication in Nature Genetics
MoreBetter together: State of Baden-Württemberg extends funding on research into bacteria-plant-synergy to enhance crop resilience
CIBSS member Junior Professor Dr. Sjon Hartman receives continued funding for his research into environmentally friendly agriculture
MoreSkin cancer: Mechanism of effect of combination immunotherapy deciphered
CIBSS member Prof. Dr. Dr. Bertram Bengsch and his team have found an explanation as to why a long-used combination therapy against malignant melanoma is more effective than the individual active substances. The results offer a therapeutic approach for many types of cancer.
MoreHighest German research prize for Freiburg cancer researcher
Gottfried Wilhelm Leibniz Prize 2025 goes to CIBSS member Prof. Dr. Robert Zeiser for his outstanding research in haematology and immunology. Zeiser's research has led, among other things, to new cancer therapies that improve patients' chances of survival and quality of life.
MoreGreat success for the iGEM Freiburg team at the Grand Jamboree in Paris 2024
The Freiburg 2024 team is awarded the prize for the Best Infectious Disease Project at the international competition for synthetic biology. A Report by Liv Neumann.
MoreEuropean Union funds research into the adaptability of tissues
CIBSS member Dr. Peter Walentek from the Medical Center – University of Freiburg receives an ERC grant of two million euros for his research on how tissues change their function through different cell types and what role this plays in diseases
More